Cargando…

Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study

BACKGROUND: Behavioral treatments can augment the success of pharmacotherapy in smoking cessation. The aim of this study was to compare smoking quit rates between patients receiving individual counseling with their general practitioner during office visits or intensive counselling with behavioral su...

Descripción completa

Detalles Bibliográficos
Autores principales: Yehoshua, Ilan, Adler, Limor, Hermoni, Sharon Alon, Mizrahi Reuveni, Miri, Bilitzky, Avital, Oren, Keren, Zacay, Galia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793508/
https://www.ncbi.nlm.nih.gov/pubmed/36575392
http://dx.doi.org/10.1186/s12875-022-01953-y
_version_ 1784859858830360576
author Yehoshua, Ilan
Adler, Limor
Hermoni, Sharon Alon
Mizrahi Reuveni, Miri
Bilitzky, Avital
Oren, Keren
Zacay, Galia
author_facet Yehoshua, Ilan
Adler, Limor
Hermoni, Sharon Alon
Mizrahi Reuveni, Miri
Bilitzky, Avital
Oren, Keren
Zacay, Galia
author_sort Yehoshua, Ilan
collection PubMed
description BACKGROUND: Behavioral treatments can augment the success of pharmacotherapy in smoking cessation. The aim of this study was to compare smoking quit rates between patients receiving individual counseling with their general practitioner during office visits or intensive counselling with behavioral support, both augmented by varenicline. METHODS: A nationwide retrospective cohort study conducted in a large Healthcare Maintenance Organization in Israel. We selected randomly patients who filled a prescription for varenicline and received either individual consulting by their general practitioner or intensive counselling with behavioural support, and asked them to answer a questionnaire. The outcome variables were smoking cessation 26–52 weeks following the beginning of treatment and satisfaction with the process. RESULTS: 870 patients were contacted and 604 agreed to participate (a response rate of 69%); 301 patients in the general practitioner group, 300 in the intensive counselling group and 3 were excluded due to missing date. The quit rate was 36.5% in the general practitioner group and 42.3% in the intensive counselling group (P = 0.147). In a logistic regression analysis, controlling for age, gender, socioeconomic status, ischemic heart disease, chronic obstructive pulmonary disease, pack years and duration of varenicline consumption, the adjusted OR for quitting in the general practitioner group was 0.79 (95% CI 0.56,1.13). The adjusted OR was higher in the group with the highest socioeconomic status at 2.06 (1.39,3.07) and a longer period of varenicline consumption at 1.30 (1.15,1.47). Age, gender and cigarette pack-years were not associated with quit rate. In the general practitioner group 68% were satisfied with the process, while 19% were not. In the intensive counselling group 64% were satisfied and 14% were not (P = 0.007). CONCLUSION: We did not detect a statistically significant difference in smoking quit rates, though there was a trend towards higher quit rates with intensive counselling.
format Online
Article
Text
id pubmed-9793508
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97935082022-12-28 Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study Yehoshua, Ilan Adler, Limor Hermoni, Sharon Alon Mizrahi Reuveni, Miri Bilitzky, Avital Oren, Keren Zacay, Galia BMC Prim Care Research BACKGROUND: Behavioral treatments can augment the success of pharmacotherapy in smoking cessation. The aim of this study was to compare smoking quit rates between patients receiving individual counseling with their general practitioner during office visits or intensive counselling with behavioral support, both augmented by varenicline. METHODS: A nationwide retrospective cohort study conducted in a large Healthcare Maintenance Organization in Israel. We selected randomly patients who filled a prescription for varenicline and received either individual consulting by their general practitioner or intensive counselling with behavioural support, and asked them to answer a questionnaire. The outcome variables were smoking cessation 26–52 weeks following the beginning of treatment and satisfaction with the process. RESULTS: 870 patients were contacted and 604 agreed to participate (a response rate of 69%); 301 patients in the general practitioner group, 300 in the intensive counselling group and 3 were excluded due to missing date. The quit rate was 36.5% in the general practitioner group and 42.3% in the intensive counselling group (P = 0.147). In a logistic regression analysis, controlling for age, gender, socioeconomic status, ischemic heart disease, chronic obstructive pulmonary disease, pack years and duration of varenicline consumption, the adjusted OR for quitting in the general practitioner group was 0.79 (95% CI 0.56,1.13). The adjusted OR was higher in the group with the highest socioeconomic status at 2.06 (1.39,3.07) and a longer period of varenicline consumption at 1.30 (1.15,1.47). Age, gender and cigarette pack-years were not associated with quit rate. In the general practitioner group 68% were satisfied with the process, while 19% were not. In the intensive counselling group 64% were satisfied and 14% were not (P = 0.007). CONCLUSION: We did not detect a statistically significant difference in smoking quit rates, though there was a trend towards higher quit rates with intensive counselling. BioMed Central 2022-12-27 /pmc/articles/PMC9793508/ /pubmed/36575392 http://dx.doi.org/10.1186/s12875-022-01953-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yehoshua, Ilan
Adler, Limor
Hermoni, Sharon Alon
Mizrahi Reuveni, Miri
Bilitzky, Avital
Oren, Keren
Zacay, Galia
Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
title Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
title_full Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
title_fullStr Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
title_full_unstemmed Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
title_short Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
title_sort smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793508/
https://www.ncbi.nlm.nih.gov/pubmed/36575392
http://dx.doi.org/10.1186/s12875-022-01953-y
work_keys_str_mv AT yehoshuailan smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy
AT adlerlimor smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy
AT hermonisharonalon smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy
AT mizrahireuvenimiri smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy
AT bilitzkyavital smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy
AT orenkeren smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy
AT zacaygalia smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy